Sonication for opening of blood-brain barrier + Carboplatin + NAB-PACLITAXEL for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Aug 2020: Trial registered, NCT04528680
  2. 29 Oct 2020: Trial started, NCT04528680

The trials

NCT04528680: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

State
Under way
Phase
Phase 1 and Phase 2
People
57 planned
Started
29 Oct 2020
Primary completion
31 Dec 2027
Arms
SC9/ABX (phase 1); SC9/ABX/Carboplatin (phase 2)
Results
None posted
  1. 27 Aug 2020: Trial registered
  2. 29 Oct 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.